Loading clinical trials...

Clinical Evaluation of Platelet Rich Fibrin Versus Subepithelial Connective Tissue Graft for Soft Tissue Augmentation | Clinical Trials | Clareo Health

UNKNOWNNA

Clinical Evaluation of Platelet Rich Fibrin Versus Subepithelial Connective Tissue Graft for Soft Tissue Augmentation

Clinical Evaluation of Platelet Rich Fibrin Versus Subepithelial Connective Tissue Graft for Soft Tissue Augmentation Around Implant in the Aesthetic Zone: A Randomized Control Clinical Trial

NCT03219944•Cairo University

View on ClinicalTrials.gov

Summary

Soft tissue biotype is a critical factor for success of implant in the esthetic zone . Different soft tissue augmentation techniques have been employed to increase soft tissue thickness such as: autogenous grafts, allografts, xenografts and living cellular construct (LCC). Studies showed that, allografts and xenografts were inferior when compared with autogenous graft . However, few studies were conducted to evaluate the efficacy of soft tissue augmentation with platelet rich fibrin in order to overcome the patient morbidity with SCTG.

Eligibility

Age

20 - 60 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Patients with missing maxillary anterior toot teeth.
•2. Thin gingival biotype.
•3. Adequate inter-arch space for placement of the implant prosthetic part.
•4. Good oral hygiene where gingival index is (0, 1) (Loe and Silness 1963).

Exclusion Criteria

•1. Patient with medical condition that is contraindicated with the surgical procedure
•2. Patients receiving treatment that affect the healing ability.
•3. Patients with local pathological defects related to the area of interest.
•4. Smokers or pregnant women.
•5. Patients with parafunctional habits that may jeopardize the implant longevity and affect the results of the study.

Locations (1)

Maymohamedkamal

Cairo, Elmaniel, Egypt

Key Dates

Start Date

August 15, 2017

Primary Completion Date

January 1, 2018

Completion Date

January 1, 2018

Last Updated

July 19, 2017

Enrollment

ESTIMATED participants

Conditions

Patients With at Least Single Missing Anterior ToothThin Gingival Biotype

Interventions

Platelet Rich Fibrin

PROCEDURE

sub epithelial connective tissue graft

PROCEDURE

Contacts

may mo kamal

CONTACT

01063392983 maykamalmo@gmail.com

A Biotype Enhancing Strategy For The Patient Undergoing Accelerated Orthodontics

NCT02866929

Class I MalocclusionOther Periodontal Diseases+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 19, 2017Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions